Guided enamel regeneration: the next generation of preventive dentistry
The aim of this webinar is to equip dental professionals with advanced knowledge and practical skills to effectively manage early-stage caries (initial decay) through early intervention, non-invasive treatment strategies.
By exploring the latest biomimetic regenerative peptide technology and its application in clinical settings, participants will gain insights into enhancing patient outcomes with an above 90% success rate in arresting and reversing early stage caries.
This webinar seeks to foster a paradigm shift and empower dentists, dental hygienists and dental therapists to deliver the next generation of early intervention, sub clinical approach to dentistry.
Learning outcomes
- Understand the importance of immediate watch area treatment: recognise the significance of addressing initial, non-cavitated carious lesions promptly, emphasising the shift away from a passive approach of 'watch and wait'
- Learn how an early intervention, sub-clinical approach can innovate caries management strategies: acquire in-depth knowledge on early intervention technique with an above 90% success rate, alongside an introduction to clinically-proven, non-invasive peptide technology, emphasising its benefits and application in dental care
- Introduction to biomimetic, regenerative, peptide technology as the new solution for watch areas: introduce participants to the clinically-proven, biomimetic peptide technology used in treating early-stage caries, focusing on its advantages and implementation in clinical practice
- Practical application of non-invasive peptide technology: explore practical applications of the non-invasive peptide technology in arresting and reversing early-stage caries through enamel regeneration, including case studies and real-world examples
- Q&A session: engage in an interactive Q&A session to address any queries related to the topics covered, providing clarity and deeper understanding of the new biomimetic technology.
Speaker: Dr Goly Abivardi
Dr Goly Abivardi, Swiss dentist, innovator, and serial entrepreneur, is the CEO and co-founder of vVARDIS a medtech company with the first product to regenerate enamel for treating incipient lesions with a medical approach. Her professional journey is shared with her sister, Dr Haley Abivardi and reflected in their joint endeavours.
Haley studied medicine and dentistry at the University of Zürich and then later co-led, along with her sister Haley, a public paediatric dental clinic linked to primary schools that emphasised preventive care, treating thousands of children from low-income backgrounds.
In 2003, she co-founded Swiss Smile, the first Dental clinic group in Switzerland and the first fear-free dental clinic group in Europe.
In parallel, she co-ran a dental hygiene school. At this time, Haley, together with her sister, came across an innovative biomimetic peptide-based technology, able to treat early caries through enamel regeneration, thereby introducing a conservative rather than a restorative approach.
To support the adoption of this technology and empower dental professionals with sub-clinical treatment strategies, she co-founded vVARDIS, a life-sciences medtech company, in 2020.
vVARDIS’ mission is to allow everyone access to the next generation of preventive dentistry, improving the oral health and overall health of the global population.
Speaker: Dr Haley Abivardi
Dr Haley Abivardi, Swiss dentist, innovator, and serial entrepreneur, is the CEO and co-founder of vVARDIS a medtech company with the first product to regenerate enamel for treating incipient lesions with a medical approach. Her professional journey is shared with her sister, Dr Goly Abivardi and reflected in their joint endeavours.
Haley studied medicine and dentistry at the University of Zürich and then later co-led, along with her sister Goly, a public paediatric dental clinic linked to primary schools that emphasised preventive care, treating thousands of children from low-income backgrounds.
In 2003, she co-founded Swiss Smile, the first Dental clinic group in Switzerland and the first fear-free dental clinic group in Europe.
In parallel, she co-ran a dental hygiene school. At this time, Haley, together with her sister, came across an innovative biomimetic peptide-based technology, able to treat early caries through enamel regeneration, thereby introducing a conservative rather than a restorative approach.
To support the adoption of this technology and empower dental professionals with sub-clinical treatment strategies, she co-founded vVARDIS, a life-sciences medtech company, in 2020.
vVARDIS’ mission is to allow everyone access to the next generation of preventive dentistry, improving the oral health and overall health of the global population.
This Continuing Professional Development (CPD) activity fully complies with the CPD requirements of the General Dental Council. FMC certifies this activity for one hour of enhanced CPD in the subject of Guided enamel regeneration: the next generation of preventive dentistry.
This CPD meets the criteria for the GDC’s development outcome C.
